STAT+: Immunovant shares surge on arthritis trial data
Meghana Keshavan·
·1 min read
·
0 reactions
·
0 comments
·
13 views
Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout
Original article
STAT · Meghana Keshavan
Anonymous · no account needed
Discussion
0 commentsMore from STAT
STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
STAT·7
STAT+: Where ‘democracy met science,’ 50 years ago
STAT·10
Opinion: In many South Asian American families, a child’s autism diagnosis is a secret
STAT·8
STAT+: One California politician’s unexpected crusade against ultra-processed food
STAT·7
Opinion: I’m a pediatrician. I want to prescribe the right AI to my patients
STAT·10
STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilis
STAT·10